The Living Guidelines: UA/NSTEMI Recomendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Polling Results for CLASS III Guidelines


 * CLASS III

Intravenous fibrinolytic therapy is not indicated in patients without acute ST-segment elevation, a true posterior MI, or a presumed new left bundle-branch block. (Level of Evidence: A)

 Additional Management Considerations for Antiplatelet and Anticoagulant Therapy CLASS III Recommendation should be: CLASS I CLASS IIa CLASS IIb CLASS III